Kimia Biosciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2025 ,inter alia, to consider and approve 1. Unaudited Standalone Financial Results of the Company for the quarter ended June 30, 2025;2. Warning Letter dated July 25, 2025 received from BSE Limited ('BSE');3. Unsecured loan of amount 2 Crores with an interest rate of 8% per annum thereof; and4. Appointment of Mr. Pradip Kumar Sharma as Chief Financial Officer ('CFO') of the Company.